Exhibit 99.1

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of Elite Pharmaceuticals, Inc.
(the "Company") on Form 10-Q for the quarter ended December 31, 2002 filed with
the Securities and Exchange Commission (the "Report"), I, Atul M. Mehta,
President and Chief Executive Officer of the Company, certify, pursuant to 18
U.S. C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

(1)      The Report fully complies with the  requirements of Section 13(a) of
         the Securities  Exchange Act of 1934; and

(2)      The information contained in the Report fairly presents, in
         all material respects, the consolidated financial condition of
         the Company as of the dates presented and the consolidated
         result of operations of the Company for the periods presented.




Date:     2/13/2003                 /s/ Atul M. Mehta
      ----------------              -------------------
                                    Atul M. Mehta
                                    President and Chief Executive Officer of
                                    Elite Pharmaceuticals, Inc.


     This certification has been furnished solely pursuant to Section 906 of
                        the Sarbanes-Oxley Act of 2002.


                                      -26-